Norton Rose Fulbright advises Berenberg on Vossloh cash capital increase

Global law firm Norton Rose Fulbright has advised Joh. Berenberg, Gossler & Co. KG investment bank (Berenberg) as Sole Lead Manager and Sole Bookrunner with respect to a capital increase of Vossloh AG against cash contributions.

The company's share capital was increased by 10 per cent by issuing 1,596,743 new no-par value ordinary bearer shares with a notional value of approximately €2.84 in the share capital against cash contributions under the exclusion of shareholders' subscription rights. This resulted in gross proceeds of around €50 million. The new shares are expected to be included in the existing listings of the company's shares in the regulated market of the Frankfurt Stock Exchange (Prime Standard) and in the regulated market of the Düsseldorf Stock Exchange on June 24, 2019.

The new shares were offered for purchase exclusively to institutional investors in a private placement by way of an accelerated bookbuilding process.

The major shareholder of the company, Heinz Hermann Thiele, has undertaken to participate in the capital increase through an investment vehicle in accordance with his shareholdings of 47.24 per cent in the company’s share capital. of the company. In return, the company has undertaken to allocate the corresponding number of shares in the capital increase to Mr. Heinz Hermann Thiele via his investment vehicle at the applicable placement price.

The Norton Rose Fulbright team that advised Berenberg was led by Frankfurt capital markets partner Benedikt Gillessen and included associate Denis Dräger.

The Norton Rose Fulbright global capital markets team covers the full range of equity and debt capital markets matters, from domestic and international equity offerings and multiple listings for large multinationals, to investment grade and high-yield debt transactions for sovereigns, banks, export credit agencies, multilaterals, institutional investors and international companies, as well as securitization and derivatives.

For further information please contact: